Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions

Por Reichart, Deborah L, Hinkle, Richard T, Lefever, Frank R, Dolan, Elizabeth T, Dietrich, Jeffrey A, Sibley, David R, Isfort, Robert J
Publicado em 2011

Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals

Por Ferreira Leonardo F, Mattson John P, Maloney Kris G, Oneill Timothy P, Zwolshen Janice M, Reichart Deborah L, Dolan Elizabeth T, Lefever Frank R, Hinkle Richard T, Musch Timothy I, Poole David C, Isfort Robert J
Publicado em 2011-01-01

Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals

Por Hinkle, Richard T, Lefever, Frank R, Dolan, Elizabeth T, Reichart, Deborah L, Zwolshen, Janice M, Oneill, Timothy P, Maloney, Kris G, Mattson, John P, Ferreira, Leonardo F, Musch, Timothy I, Poole, David C, Isfort, Robert J
Publicado em 2011

Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice

Por Stevens Paula J, Demuth Jeffrey P, Thacker Robert I, Gropp Kathryn E, Dietrich Jefferey A, Reichart Deborah L, Dolan Elizabeth T, Lefever Frank R, Hinkle Richard T, Qu Xiaoyan A, Varbanov Alex R, Wang Feng, Isfort Robert J
Publicado em 2007-07-01

Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice

Por Hinkle, Richard T, Lefever, Frank R, Dolan, Elizabeth T, Reichart, Deborah L, Dietrich, Jefferey A, Gropp, Kathryn E, Thacker, Robert I, Demuth, Jeffrey P, Stevens, Paula J, Qu, Xiaoyan A, Varbanov, Alex R, Wang, Feng, Isfort, Robert J
Publicado em 2007